US Patent 7491799 Modified botulinum neurotoxins
Patent 7491799 was granted and assigned to Allergan, Inc. on February, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 14, 2004
Date of Patent
February 17, 2009
Patent Application Number
10757077
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7491799 Modified botulinum neurotoxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.